2C-T-19
 | |
 | |
| Names | |
|---|---|
| Preferred IUPAC name 2-[4-(Butylsulfanyl)-2,5-dimethoxyphenyl]ethan-1-amine | |
| Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
| ChemSpider |
|
PubChem CID |
|
| UNII |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
| Properties | |
Chemical formula | C14H23NO2S |
| Molar mass | 269.40 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).  Y verify (what is  Y N ?) Infobox references | |
Chemical compound
2C-T-19 (2,5-dimethoxy-4-butylthiophenethylamine) is a psychedelic phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin.
Dosage
In his book PiHKAL, Shulgin describes synthesis of the final intermediate of 2C-T-19 but did not bioassay the compound.[1]
Legality
Canada
As of October 31, 2016, 2C-T-19 is a controlled substance (Schedule III) in Canada.[2]
United States
In the United States, 2C-T-19 is not specifically scheduled, but possession and sales of 2C-T-19 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.
References
- v
- t
- e
2C family of psychedelics
- 2C-B
- 2C-B-AN
- 2C-Bn
- 2C-Bu
- 2C-C
- 2C-CN
- 2C-CP
- 2C-D
- 2C-E
- 2C-EF
- 2C-F
- 2C-G
- 2C-G-1
- 2C-G-2
- 2C-G-3
- 2C-G-4
- 2C-G-5
- 2C-G-6
- 2C-G-N
- 2C-H
- 2C-I
- 2C-iP
- 2C-N
- 2C-NH2
- 2C-O
- 2C-O-4
- 2C-P
- 2C-Ph
- 2C-SE
- 2C-T
- 2C-T-2
- 2C-T-3
- 2C-T-4
- 2C-T-5
- 2C-T-6
- 2C-T-7
- 2C-T-8
- 2C-T-9
- 2C-T-10
- 2C-T-11
- 2C-T-12
- 2C-T-13
- 2C-T-14
- 2C-T-15
- 2C-T-16
- 2C-T-17
- 2C-T-18
- 2C-T-19
- 2C-T-20
- 2C-T-21
- 2C-T-22
- 2C-T-22.5
- 2C-T-23
- 2C-T-24
- 2C-T-25
- 2C-T-27
- 2C-T-28
- 2C-T-30
- 2C-T-31
- 2C-T-32
- 2C-T-33
- 2C-TFE
- 2C-TFM
- 2C-YN
- 2C-V
